Publications by authors named "Pilar Callau"

Claim this Profile
R
Results of a fast-track HIV and hepatitis C screening protocol in Barcelona, Spain.
Iván Chivite, Vanessa Guilera, Pilar Callau, Raquel Aguiló, Elisa de Lazzari

PLoS One· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Health Outcomes of People with HIV Engaged in Chemsex: A Prospective Cohort Study on Drug Use, Sexual Behaviour, Sexually-Transmitted Infections and Vulnerability.
Lorena De La Mora, Montserrat Laguno, Berta Torres, Ivan Chivite, Alberto Foncillas, Pilar Callau

Infect Dis Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory Bowel Disease Is an Independent Risk Factor for Metabolic Dysfunction-Associated Steatotic Liver Disease in Lean Individuals.
Samuel J Martínez-Domínguez, Sandra García-Mateo, Carla J Gargallo-Puyuelo, Beatriz Gallego-Llera, Pilar Callau

Inflamm Bowel Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crohn´s disease is an independent risk factor for liver fibrosis in patients with inflammatory bowel disease and non-alcoholic fatty liver disease.
Samuel J Martínez-Domínguez, Sandra García-Mateo, Carla J Gargallo-Puyuelo, Beatriz Gallego Llera, Engy Refaie, Pilar Callau

Eur J Intern Med· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).
Alexy Inciarte, Ainoa Ugarte, María Martínez-Rebollar, Berta Torres, Emma Fernández, Pilar Callau

Open Forum Infect Dis· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simplification from tenofovir disoproxil fumarate plus lamivudine or emtricitabine plus ritonavir-boosted protease inhibitor to ritonavir-boosted atazanavir plus lamivudine in virologically suppressed HIV-infected adults with osteopenia: a pilot study.
José L Blanco, Jhon Rojas, Elisa de Lazzari, Alexy Inciarte, Mar Subirana, Pilar Callau

J Antimicrob Chemother· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study.
Alexy Inciarte, Ana Gonzalez-Cordon, Jhon Rojas, Berta Torres, Elisa de Lazzari, Pilar Callau

AIDS· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis